Wego Health taps Fetterolf for Truvio

Share this article:
Ross Fetterolf
Ross Fetterolf

Wego Health announced it would bolster its roster with the addition of Ross Fetterolf as SVP of innovation. Fetterolf will assume the role of product director for WEGO Health's Truvio, a mobile healthcare research platform. He will also provide support in the areas of strategy and analytics.

Fetterolf was a part of the management reshuffle at Palio+Ignite earlier this month, when two other senior execs, former president and co-founder Mike Myers and erstwhile chief creative officer Brian Lefkowitz also left the company. Fetterolf served as the SVP of digital strategy and analytics at Palio+Ignite, where he led the agency in developing digital and social media strategies as well as measurement plans.

Fetterolf's background has spanned a number of digital health agencies including Ignite Health, Medical Broadcasting Company (now Digitas Health) and i-Frontier (now Razorfish Health). 

At Wego, Fetterolf reunites with another Palio+Ignite veteran, Fabio Gratton, who after leaving the agency in May founded a digital health incubator called Alchemy Factory, and in September co-founded Vocalize, the cloud-based market research service that offers Truvio.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.